KIRK RANDAL J 4

What Happened
Randal J. Kirk (listed as a 10% owner) acquired 28,490 shares of Precigen common stock at $3.51 per share for a total cash value of $100,000 and was also granted two derivative awards totaling 153,372 restricted stock units (71,225 and 82,147 RSUs) on March 10, 2026. The filing classifies all items as acquisitions (code A).

Key Details

• Transaction date: 2026-03-10; filing date: 2026-03-12 (appears timely — Form 4s are generally due within two business days).
• Acquired 28,490 shares at $3.51 each = $100,000.
• Granted 71,225 RSUs and 82,147 RSUs (total 153,372 RSUs) with $0 purchase price listed (derivative awards).
• Shares owned after the transaction are not stated in the provided summary.
• Footnote F1: Mr. Kirk controls multiple entities (listed in the filing); shares held by those entities may be deemed beneficially owned by him, though he disclaims beneficial ownership except for any pecuniary interest.
• Footnote F2: Each RSU represents a contingent right to one share and vests on the one-year anniversary of the grant, subject to Mr. Kirk’s continued service.

Context

• The 28,490-share acquisition is a direct economic purchase (cash value shown). The RSUs are derivative awards that will convert into shares only upon vesting (no immediate shares issued).
• As a 10% owner controlling several entities, Mr. Kirk’s filings reflect both personal and control-related holdings; this is different from routine employee open-market trading.
• Purchases and grants can be of interest to investors, but they do not by themselves reveal motivation; the RSUs are service-vesting awards rather than immediate market buys.